Facharzt İsmail Güzeliş
Kurzbiografie
Dr. İsmail Güzeliş ist im Fachgebiet Pathologie tätig. Der Abschluss an der Medizinischen Fakultät der Manisa Celal Bayar Üniversitesi erfolgte im September 2019. Die Facharztausbildung in medizinischer Pathologie wurde von 2019 bis 2024 an der İzmir Kâtip Çelebi Üniversitesi absolviert; 2025 begann das Promotionsstudium in molekularer Pathologie.
Ausbildung
- Medizinstudium: Medizinische Fakultät der Manisa Celal Bayar Üniversitesi, 2012–2019. Abschlussdatum: 09.2019.
- Facharztausbildung: Medizinische Fakultät der İzmir Kâtip Çelebi Üniversitesi, Abteilung für Medizinische Pathologie. Beginn: 12.2019. Ende: 04.2024.
- Promotion: Institut für Gesundheitswissenschaften der İzmir Dokuz Eylül Üniversitesi, Abteilung für Molekulare Pathologie. Beginn: 09.2025.
Berufserfahrung
- Medizinische Fakultät der İzmir Kâtip Çelebi Üniversitesi, Abteilung für Medizinische Pathologie. Beginn: 12.2019. Ende: 06.2024.
- İzmir Buca Seyfi Demirsoy Ausbildungs- und Forschungskrankenhaus, Klinik für Medizinische Pathologie. Beginn: 06.2024. Ende: 09.2026.
- İzmir Tınaztepe Üniversitesi Buca Medizinisches Zentrum, Medizinische Pathologie, Assistant Professor. Beginn: 09.2026.
Wissenschaftliche Arbeiten und Veröffentlichungen
Artikel
- I. GUZELIS, R. GASIMLI, A. SUBASIOGLU & A. SARI, Clinicopathological and genotypic characteristics of colorectal cancer patients carrying a germline MUTYH mutation, REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2026, 0104-4230, 72, 2, 7, WOS.
- İ. GÜZELİŞ, M. A. UYAROĞLU & İ. ONUR, A cytohistological correlation: Proliferative breast disease with atypia, Cytojournal, 2025, 0974-5963, 22, YÖK.
- İ. GÜZELİŞ, B. B. KÜÇÜKZEYBEK, M. G. BULUT, Y. Y. BOZOK & Y. KÜÇÜKZEYBEK, Does SOX-2 expression have a prognostic value in triple-negative breast cancer?, Polish Journal of Pathology, 2025, 1233-9687, 76, YÖK.
- A. G. D. ÜNLÜ, İ. GÜZELİŞ, D. S. KAHRAMAN, D. AYAZ, U. VAROL & M. DEĞİRMENCİ, Evaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer, European Journal of Breast Health, 2025, 2587-0831, YÖK.
- Y. SÜR, E. Ö. GÜR, F. CENGİZ, A. SUBAŞIOĞLU, İ. GÜZELİŞ, S. DEMİR, A. SARI, M. HACIYANLI & O. N. DİLEK, Lynch syndrome association and clinicopathological features in early-onset colorectal cancers: A single-center retrospective study, World Journal of Clinical Oncology, 2025, 2218-4333, 16, YÖK.
- İ. GÜZELİŞ, B. B. KÜÇÜKZEYBEK, M. A. UYAROĞLU, M. GÖKOVA, G. SEZGİN & Y. KÜÇÜKZEYBEK, HER2-positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature, Diagnostic Cytopathology, 2024, 8755-1039, 52, YÖK.
- A. KAHRAMAN, F. DİRİLENOĞLU, İ. GÜZELİŞ & Y. K. ÇETİNOĞLU, Intraoperative pathologic diagnosis of central nervous system lymphomas: A comparison of frozen and permanent section diagnoses, and the significance of preoperative imaging, Annals of Diagnostic Pathology, 2024, 1092-9134, 69, YÖK.
- N. Ö. ELİYATKIN, İ. GÜZELİŞ, C. TAVUSBAY & M. G. BULUT, Memede Kollizyon Tümörü: Heterolog Komponentli Malign Filloides Tümör ve İnvaziv Meme Karsinomu, Spesifiye Edilemeyen Tip, OSMANGAZİ JOURNAL OF MEDICINE, 2023, 1305-4953, 46, YÖK.
- A. ÇALLI, G. ISSIN, İ. YILMAZ, D. İNCE, E. TURAL, İ. GÜZELİŞ, R. E. ÇEÇEN, H. N. OLGUN, D. GÖKÇAY & E. ÖZER et al., The association of miR-204 and mir-483 5p expression with clinicopathological features of Wilms tumor: Could this provide foresight?, Japanese Journal of Clinical Oncology, 2023, 1465-3621, 53, YÖK.
- İ. ÖCAL & İ. GÜZELİŞ, Prognostic Significance of Tumor Budding in Urothelial Carcinomas of the Bladder: Comparison of Two Different Tumor Budding Evaluation Methods, Medical Records, 2022, 2687-4555, 4, YÖK.
- İ. ÖCAL & İ. GÜZELİŞ, Tumor budding is a valuable prognostic parameter in endometrial carcinomas, Indian Journal of Pathology and Microbiology, 2022, 0377-4929, 65, YÖK.
- İ. ÖCAL, F. U. DUMAN, Z. A. ÖCAL, F. ÇAKALAĞAOĞLU, M. O. HORASANLI & İ. GÜZELİŞ, Idiopathic Scrotal Calcinosis, Analysis of Epithelial Origin by Immunhistochemical Methods, Southern Clinics of Istanbul Eurasia, 2021, 25870998, YÖK.
Vorträge
- İ. GÜZELİŞ, A. G. DİNİZ ÜNLÜ, Y. ADALI, Ö. ÖZ & T. TURAN, PROSTATE ADENOCARCINOMA GLEASON SCORING: DOES IT DIFFER BETWEEN NEEDLE BIOPSY AND RADICAL PROSTATECTOMY, Mündlicher Vortrag, 13. Uluslararası Artemis Bilimsel Araştırmalar Kongresi, 28 Ağustos 2025–30 Ağustos 2025.
- İ. GÜZELİŞ & F. H. DİLEK, Meme Karsinomunun Gastrointestinal Yola Metastazı: 3 Olguluk Vaka Takdimi, Mündlicher Vortrag, 19. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi, 12 Temmuz 2025–13 Temmuz 2025.
- İ. GÜZELİŞ, A. G. DİNİZ ÜNLÜ, Y. ADALI, G. YAVAŞ & H. ŞİMŞEK, Moleküler Patoloji Çağında Beyin Cerrahi Materyallerinin Histopatolojik Değerlendirilmesi, Mündlicher Vortrag, 19. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi, 12. Juli 2025–13. Juli 2025.
- B. BOLAT KÜÇÜKZEYBEK & İ. GÜZELİŞ, The Prognostic Value of Stromal TumorInfiltrating Lymphocytes in Triple-Negative Breast Cancer with No Prior Neoadjuvant Treatment, Mündlicher Vortrag, 6TH INTERNATIONAL MEDICAL CONGRESS OF IZMIR DEMOCRACY UNIVERSITY, 05. Dezember 2024–06. Dezember 2024.
- İ. GÜZELİŞ, A. SUBAŞIOĞLU & A. SARI, Clinicopathological characteristics and genotypes of MUTYH mutated colorectal cancer patients in the Turkish population, Posterpräsentation, 36th European Congress of Pathology, 07. September 2024–11. September 2024.
- İ. GÜZELİŞ, B. BOLAT KÜÇÜKZEYBEK, M. GÜRSOY, Y. YILMAZ BOZOK & Y. KÜÇÜKZEYBEK, Prognostic value of SOX-2 nuclear expression in triple- negative breast cancer, Posterpräsentation, 36th European Congress of Pathology, 07. September 2024–11. September 2024.
- L. D. GÜLKANAT, İ. E. ÇAKIR, İ. GÜZELİŞ, F. ÇAKALAĞAOĞLU & A. KAHRAMAN, Histopathologic patterns in brain metastases of lung adenocarcinoma: does it affect the survival?, Posterpräsentation, 34th European Congress of Pathology, 03. September 2022–07. September 2022.
- A. ÇALLI, G. ISSIN, İ. YILMAZ, D. İNCE, E. TURAL, İ. GÜZELİŞ, R. E. ÇEÇEN, H. N. OLGUN, D. GÖKÇAY & E. ÖZER, The association of mir-204 and mir-483 5p expression with clinicopathological features of Wilms tumour: could provide foresight?, Posterpräsentation, 34th European Congress of Pathology, 03. September 2022–07. September 2022.
- İ. GÜZELİŞ, F. ÇAKALAĞAOĞLU, I. E. SEVIN & B. B. YENEN, WHO 2021 histopathological grading of atypical and anaplastic meningiomas, Posterpräsentation, 34th European Congress of Pathology, 03. September 2022–07. September 2022.
- İ. GÜZELİŞ, İ. E. ÇAKIR & M. A. UYAROĞLU, A case report: micronodular thymoma with lymphoid stroma, and thymic cysts, Posterpräsentation, 33rd European Congress of Pathology, 29. August 2021–31. August 2021.
- İ. GÜZELİŞ, S. YİĞİT & A. YILDIZ, An early stage ovarian carcinosarcoma and its association with primary tubal carcinoma, Posterpräsentation, 33rd European Congress of Pathology, 29. August 2021–31. August 2021.
Berufsverbände
- Ägäischer Pathologieverband, 2020.
- Europäische Gesellschaft für Pathologie, 2020.

